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Abstract.  We have previously reported the use of 
monoclonal antibodies to identify a  140-kD cell sur- 
face glycoprotein in mammalian cells that is 
specifically involved in fibronectin-mediated cell adhe- 
sion. We now report the purification of this molecule 
using immunoaffinity chromatography and the subse- 
quent generation of polyclonal antibodies that selec- 
tively immunoprecipitate 140-kD putative fibronectin 
receptor glycoprotein (gpl40) extracted from rodent or 
human cells; these antibodies also specifically block 
fibronectin-mediated cell adhesion but not adhesion 
mediated by other factors in serum.  Expression of 
gpl40-1ike molecules was detected on the surfaces of 
several adherent human cell lines (HDF, WISH, and 
EFC) but not on erythrocytes; however, gpl40 was 
also detected on a nonadherent human lymphoid line 
(DAUDI).  Analysis of gpl40 on nonreducing SDS gels 
revealed two closely migrating bands.  Protease diges- 
tion and peptide mapping suggests that the two bands 
are closely related polypeptides. 
T 
HE adhesion of cells to the extracellular matrix is a 
complex, multistage process. An early stage presum- 
ably  involves  interaction between  adhesive  protein 
ligands in the matrix such as fibronectin (Fn), ~  vitronectin, 
or laminin, and their receptors on the cell surface (4, 22, 32, 
33). Later stages include cellular metabolic activities and the 
recruitment of cytoskeletal elements involved in morphologi- 
cal changes and cell spreading (9, 13). Fn, a major adhesion 
ligand for mesenchymal cells,  is a  complex multidomain 
protein (16). Recently most of the adhesion promoting activ- 
ity of Fn has been shown to reside in a tetrapeptide segment 
that is part of one domain of the molecule (25); however the 
overall conformation of the Fn molecule may also be impor- 
tant  in  modulating  the  adhesion  activity  of this  protein 
(29-31). 
Establishment of the identity of the surface receptor for Fn 
has  been  elusive,  probably  because  of the  relatively low 
affinity of soluble Fn for its receptor (2, 22).  Investigators 
have suggested several molecular classes, including glycolip- 
ids (8) and proteoglycans (21), as candidates. Recently, how- 
ever, attention has mainly focused on cell surface glycopro- 
teins as the receptors  involved in the adhesion promoting 
functions of Fn (19, 24, 28). Thus our laboratory has recently 
described two monoclonal antibodies (designated PB1  and 
PB2) that can selectively inhibit Fn-mediated adhesion in 
hamster fibroblastic cells  (Chinese hamster ovary [CHO] 
line) without affecting adhesion processes mediated by lami- 
1. Abbreviations  used in this paper:  CHO, Chinese hamster ovary; DPBS, 
Dulbecco's PBS; Fn, fibronectin; gpl40,  140-kD putative Fn receptor glyco- 
protein;  L  band,  lower  band;  NGIgG,  nonimmune  goat  IgG;  NP-40, 
Nonidet P-40;  U band, upper band. 
nin, vitronectin, or the complex mixture of adhesion factors 
in serum (6).  Both monoclonals immunoprecipitate a  140- 
kD glycoprotein from cells labeled biosynthetically (pH]- 
glucosamine,  [35S]methionine),  or  with  1251 using  surface 
radioiodination. Ruoslahti's laboratory has also recently de- 
scribed a 140-kD protein isolated from human osteosarcoma 
cells that binds to Fn affinity columns and is  specifically 
eluted by a  hexapeptide with adhesion promoting activity 
(26).  The  140-kD components  described  above  are  thus 
likely candidates for the mammalian cell Fn receptor. The 
140-kD  component may also be a  member of a  group of 
adhesion-related  glycoproteins  previously  described  in 
mammalian cells (19, 11). In avian cells, adhesion has been 
associated with a  complex composed of three distinct cell 
surface glycoproteins with  molecular masses  of  155-160, 
135, and 110-120 kD (7, 18, 23). Thus, it is becoming evident 
that the cellular receptors for Fn in a variety of cells, are 
likely to comprise one or more cell surface glycoproteins. 
We wished to explore the expression and function of the 
140-kD putative Fn receptor glycoprotein (gpl40) in adhesive 
and nonadhesive mammalian cells. However,  the monoclo- 
nal antibodies PB1 and PB2 were so selective that they recog- 
nized the gpl40 molecule in CHO cells but not in human or 
murine cell lines. For this reason we elected to use the PB1 
monoclonal to purify gpl40 to apparent homogeneity and 
subsequently raised a  polyclonal antibody to this compo- 
nent.  In  this  report  we  demonstrate  that  the  polyclonal 
anti-gpl40 antibody specifically immunoprecipitates gpl40 
in CHO cells. Furthermore, the polyclonal antibody, like the 
PB1 and PB2 monoclonals, selectively blocks Fn-dependent 
cell adhesion, but not other adhesion processes. Polyclonal 
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cross-reactive glycoproteins of similar molecular mass in a 
number of human cell lines. This antibody affects the adhe- 
sion and morphology of cells expressing gpl40-1ike mole- 
cules on their surfaces including fibroblasts, amnion cells, 
and glioma cells.  Thus evidence suggests that cell surface 
molecules similar to CHO cell gpl40 play a role in the Fn- 
mediated adhesion processes of a number of cell types. 
Materials and Methods 
Cell Culture 
CHO cells were grown and maintained in suspension culture as previously 
described (12). Human diploid fibroblasts (HDF) (a gift of Dr. C. Moore, 
Shriner's Children Hospital, Houston, TX) were grown in Eagle's minimum 
essential alpha medium (Gibco, Grand Island, NY) supplemented with 10% 
fetal bovine serum (Hazleton Research Products, Inc., Denver, PA) and 1% 
antibiotics (Gibeo).  The  human cell  lines,  EFC  (glioblastoma),  WISH 
(amnion), and DAUDI (lymphoblastoid), were provided by Dr. P. J. Kelle- 
her (M.D. Anderson Hospital, Houston, TX). Suspension cells (CHO and 
DAUDI) were harvested by centrifugation when the cell density attained 
8  ×  lO  s cells/ml and washed three times with Dulbecco's PBS (DPBS). 
Subconfluent monolayer cultures (HDF, WISH,  and EFC) were washed 
three times with DPBS and the cells removed by treatment with 5  mM 
EDTA in DPBS and scraping. 
Protein Determination 
Protein concentrations were determined using the BCA protein assay re- 
agent according to the manufacturer's directions (Pierce Chemical Co., 
Rockford, IL). BSA was used as the standard. 
Radiolabeling 
CHO cells were metabolically labeled with 4  ~Ci/mi  [3H]leucine  over- 
night in suspension culture. Cells (2-3  ×  107) were surface-labeled with 
1 mCi [Na]125I using the Iodogen  R surface-labeling technique (17). 
Preparation of  Affinity Columns 
Monoclonal antibody PB1 was purified from ascites fluid as described  previ- 
ously (6),  and covalently coupled to At]i-gel  10  (Bio-Rad Laboratories, 
Richmond, CA) as recommended by the manufacturer. The resulting gel 
contained oo15-20  mg/ml covalently coupled monoclonal antibody. Goat 
anti-gpl40 and preimmune goat IgG were covalently coupled to Afli-gel 10 
with oo25 nag antibody/ml of Afii-gel for each. 
Isolation of  gpl40 
Approximately 2  ×  101° CHO cells were harvested by centrifugation at 
750 g for 10 min and were washed twice with ice cold DPBS. The cell pellet 
(5  ×  107 cells/ml) was extracted with 20 mM Tris HCI (pH 8.3),  100 mM 
NaCI,  1%  Nonidet P-40 (NP-40),  0.1%  NAN3, 2  mM phenylmethylsul- 
fonyl floride, and 1 mM EDTA (lysis buffer) for 60 min at 4°C with occa- 
sional vortexing. The cell extract was centrifuged for 1 h at 42,400 g (JA-21, 
JA-20 rotor; Beckman Instruments Inc., Fullerton, CA) and for 45 rain at 
150,000 g (L5-40, 70.1 Ti rotor; Beckman Instruments Inc.). The superna- 
tant was first applied to a Sepharose C1-4B (10 ml bed volume; Pharmacia 
Fine Chemicals Inc., Piseataway,  NJ) column previously equilibrated in ly- 
sis buffer to remove any nonspecific binding material from the extract. The 
flow through from the Sepharose column was pumped onto a prewashed im- 
munoaffinity column. The column consisted of 70 mg of PBI monoclonal 
covalently coupled to 5 mi AIfi-gel 10 according to the manufacturer's direc- 
tions. The sample was passed twice over the PB1 immunoaffinity column. 
The column was washed with 20 bed volumes of  TNEN buffer (20 mM Tris 
HCI [pH 8.2],  100 mM NaCI,  1 mM EDTA, 0.5% NP-40, 0.5%  sodium 
deoxycholate, and 0.1% SDS) (5) and eluted with 0.2 N acetic acid, (pH 
2.5), 1130 mM NaCI, and 1% NP-40. l-ml fractions were collected and neu- 
tralized to pH 7.3 with 0.233 ml  1 M  Tris. 
Production of  Polyclonal  Anti-gpl4O Antibodies 
Antiserum against gpl40 was produced in a  l-yr-old male goat by three in- 
jections at 2-wk intervals of 100 ltg gpl40 mixed 1:1 with complete Freund's 
adjuvant. Half of the gpl40 (50 I.tg) was in its native state while 50 p.g had 
been blotted onto nitrocellulose and dissolved in dimethyl sulfoxide. Serum 
was collected 1 wk after the third immunization and tested for anti-CHO 
binding in an enzyme-linked immunosorbant assay using anti-goat-horse- 
radish peroxidase conjugate (Cappel Laboratories, Cochranville, PA) with 
O-phenylenediamine (Sigma Chemical Co.,  St.  Louis, MO) as the sub- 
strate. The IgG fraction of the antiserum was obtained by two ammonium 
sulfate fractionations, (30 and 45%).  The final pellet was dissolved in a 
minimum volume of DPBS and dialyzed against four changes of DPBS at 
100 times the volume of the dissolved pellet. 
Immunoprecipitations 
125I surface-labeled cells were extracted with lysis buffer (1  ×  107 cells/ml) 
for 60 min at 4°C and were subsequently centrifuged at 12,500 g in an Ep- 
pendorf microfuge for 15 min. The supernatant was passed over a 0.5-mi 
column of Sepharose CI-4B pre-equilibrated in a  lysis buffer.  The flow 
through was collected and the protein concentration of each sample was de- 
terrnined by the Pierce BCA Protein assay. The specific activity was deter- 
mined by 10% TCA precipitation ofa 10-~tl aliquot with 20 ~tg bovine albu- 
min providing carrier protein. The pellet was washed twice with 10% TCA 
and counted in a gamma counter. The protein concentration of each sample 
was adjusted to 360 ~tg/rnl and 1.2 ml added to 50 Ixl Atti-gel 10 coupled 
to goat-anti gpl40 (1.2 rng) or 50 I.tl Affi-gel 10 coupled to preimmune goat 
(1.2  rag).  In  addition,  some  samples  of  CHO  cells  were  also  im- 
munoprecipitated with PB1 monoclonal coupled to Afii-gel. The immuno- 
precipitations were carried out at 4°C for 4 h on a rotating platform. The 
samples were washed four times with TNEN buffer and solubilized by boil- 
ing with 1130 I11 Laemmii sampler buffer with 2-mercaptoethanol (20). 
Electrophoresis 
SDS PAGE was carried out essenti  .ally according to the method of Laemmli 
(20) except that both the stacking and separating gels contained 0.3 % linear 
polyacrylamide (Polysciences Inc., Warrington, PA) (13). 
Adhesion Blocking Assays 
The wells of 24 well tissue culture plates were coated with the appropriate 
ligand (Fn, 100 Ixg/rnl or Fn-depleted serum, 20%) according to published 
procedures (12, 13). Dilutions of goat anti-gpl40 or preimmune goat IgG 
(NGIgG) were made in ice cold Eagle's essential minimum alpha medium 
with 0.1% BSA and 1% antibiotics (adhesion medium) and were added to 
the ligand-coated wells.  1-2  ×  Its washed cells were pipetted into each 
well and the plate incubated at 4°C for 60 min to allow antibody binding. 
The plates were then transferred to 370C and incubated for a period of time 
allowing control cells to attach and spread. For CHO cells, the time required 
was 60 min, whereas the other cell lines required 3 h. In some experiments 
monolayers were formed followed by the addition of the appropriate anti- 
body dilutions. The plates were then incubated at 37°C for 18 h and results 
recorded photographically. All experiments were done in triplicate. 
Determination of  the Number of  gp140-Binding Sites 
Suspension culture CHO cells were washed with PBS and fixed with 3% 
formaldehyde for 10 min at room temperature. The cells were washed with 
PBS and with Eagle's essential minimum alpha medium and resuspended 
at 5  ×  10  7 cells in PBS plus 0.2% BSA. PBI monoclonal antibody was ra- 
diolabeled using Protag-125 TM (J.T. Chemical Baker Co., Phillipsburg, NJ) 
according to the manufacturer's protocol. Dilutions of radiolabeled antibody 
were made in PBS with 0.2%  BSA and  1 mg/ml mouse gamma globulin 
or with PBS 0.2% BSA and 80 I.tg/ml cold PBI monoclonal antibody. 100 
I11 of cell suspension (5  ×  106 cells) was added to each tube and the bind- 
ing carried out at 4°C for 2 h. After the incubation, the cells were spun down 
and a 100-I.tl aliquot of  the supernatant retained for determining free labeled 
antibody. The cells were washed four times and then counted in a gamma 
counter. 
Immunoblotting 
Samples of adhesion-related proteins and antibodies to these proteins were 
compared by immunoblot techniques. 100 Ixl of appropriate dilutions of an- 
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Laboratories) with a nitrocellulose membrane and allowed to bind during 
gravity  filtration.  The membrane was air dried and stored until use.  The 
membrane was blocked with 3% gelatin in Tris-buffered saline (pH 7.5) (20 
mM Tris,  and 500 mM NaCI)  for 30-60 min and then incubated with an 
appropriate dilution of primary antibody in 1% gelatin in Tris-buffered  sa- 
line for 2 h at 25°C with gentle agitation.  The membrane was washed with 
two changes of 0.05 % Tween 20 in Tds-buffered saline followed by incuba- 
tion  with  horse  radish  peroxidase-coupled  second  antibody  (BioRad 
Laboratories) (1/1000 in 1% gelatin in TBS), and washed and developed in 
horse radish peroxidase color development solution. The antigens and anti- 
bodies used were (a) normal goat IgG; (b) goat anti-hamster gpl40 IgG; 
(c) afffinity-purified  goat anti-hamster gpl40 IgG; (d) affinity-purified rabbit 
anti-human Fn receptor IgG (19) obtained from E. Ruoslahti,  La Jolla Can- 
cer Research Center Foundation, La Jolla, CA; (e) normal rabbit IgG; (f) 
rabbit anti-CSAT antigen serum; (g) normal rabbit serum; and (h) CSAT 
antigen (23).  Items f-h were obtained from C.  Buck (Wistar  Institute of 
Anatomy and Biology,  Philadelphia, PA). 
Peptide Mapping 
Two-dimensional  peptide maps of radioiodinated  upper (U) and lower (L) 
gpl40 bands were prepared by the method of Elder et al.  (10). Briefly, 
purified gpl40 was resolved on a 6% nonreducing gel. Gel regions contain- 
ing the resolved U and L bands were identified by Coomassie Blue staining. 
Slices  containing the separated  U  and L  bands were  l~I-labeled in situ 
using chloramine T as described (10). After removal of excess isotope,  the 
proteins were digested overnight at 37°C with 50 ~tg/ml each of trypsin and 
chymotrypsin in 50 mM NI-LCO3 buffer  (pH 8). The supernatants were 
lyophilized,  rehydrated  in appropriate buffer, and then spotted onto cellu- 
lose-coated  thin layer chromatography plates and resolved  by high voltage 
electrophoresis in the first dimension and thin layer chromatography in the 
second dimension. The electrophoresis buffer was acetic acid/formic acid/ 
water (15:5:80), whereas the chromatography solvent was butanol/pyridinel 
acetic acid/water (33:25:5:20). The dried thin layer chromatography  plates 
were autoradiographed  on Kodak  XRP film to visualize the ~I peptides 
generated.  Approximately  equal cpm were spotted on to the plates for analy- 
sis of U or L bands. 
Results 
gpl40 in CHO Cells 
As shown previously, monoclonal antibodies PB1 and PB2 
Figure 1. Immunoprecipitation of cell surface proteins by adhesion 
blocking monoclonals.  12~I surface-labeled cells were  solubilized 
in 1% NP-40 plus 1 mM phenylmethylsulfonyl fluoride in PBS and 
lysates subjected to  immunoprecipitation using monoclonal anti- 
bodies  coupled  to  Protein  A  Sepharose  beads  (Pharmacia  Fine 
Chemicals) via rabbit anti-mouse IgG (Miles Laboratories,  Inc., 
Elkhart,  IN).  Approximately  1  x  107 cell equivalents were  im- 
munoprecipitated and 1-2  x  106 cell equivalents were run in each 
lane.  Lane  a,  Control,  no  monoclonal  antibody;  lane  b,  PB1 
monoclonal antibody; lane c,  PB2 monoclonal antibody; lane d, 
3F9  monoclonal  antibody;  lane  e,  total  t25I-labeled cell  surface 
proteins.  7.5 %  SDS PAGE run under reducing conditions. 
specifically inhibit Fn-mediated adhesion in CHO cells (6); 
these antibodies selectively precipitate a 140-kD cell surface 
glycoprotein from the cells. This result is confirmed in Fig. 
1 where lanes b and c show the immunoprecipitation pattern 
on SDS PAGE of PB1  and PB2 respectively, while lane d 
shows the immunoprecipitation pattern for 3F9, an unrelated 
monoclonal that does not block adhesion and that precipi- 
tates a cell surface component with a molecular mass of 265 
kD. The band precipitated by PB1 and PB2 is one member 
of a complex of L~5I-surface  labeled proteins in the 130-150- 
kD range (lane e) (13). 
The gpl40 antigen is moderately abundant on the cell sur- 
face. Thus binding assays with 125I-labeled PB1  shows  that 
saturation occurs at a concentration of •10  nM PB1 with 0.7 
pmol/106 cells specifically bound (Fig.  2 A).  A  Scatchard 
analysis of  the data indicates a single PB1 binding site present 
at *1  x  105 copies per cell and having an affinity of 5  x 
108 M  (Fig.  2  B).  It is not clear if the apparent deviation 
from linearity at low PB1 concentration represents positive 
cooperativity, or simply reflects errors in the data due to low 
counts.  The number of PB1 binding sites agrees well with 
previous estimates  of the numbers of cell surface binding 
sites for Fn (1, 3, 22). 
gpl40 was purified from NP-40 lysates of CHO suspension 
cells using PB1 coupled to Affi-gel 10 as affinity column (see 
Materials and Methods). Judged by silver staining after SDS 
PAGE, gpl40 appears to be homogeneous (Fig. 3). Approxi- 
mately 600 ~tg purified gpl40 was obtained from 2  ×  101° 
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Figure 2.  Binding of PB1 monoclonal antibody to CHO cells.  125I 
PB1 binding to fixed CHO  suspension cells was measured as de- 
scribed in Materials and Methods. Specific binding was calculated 
by the difference in the clam bound in the absence and presence of 
500 nM "cold" PB1. Points represent means of triplicate determina- 
tions  differing  by  <5%.  (A)  Specific  binding  in  picomoles/106 
cells.  (B) Scatchard plot. 
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antibody affinity column was used to purify gpl40 from CHO cells 
as described in Materials and Methods. The samples were analyzed 
by 7.5 % SDS PAGE under reducing conditions, and detected by sil- 
ver staining.  (A) Fractions eluted from the PB1 affinity column with 
0.2 N acetic acid. Fractions 8-14 were retained for polyclonal anti- 
body production.  (B) The original CHO cell lysate. 
cells, an amount representing 0.03 % total cell protein. If one 
assumes one PB1 binding site per gp140 molecule expressed 
at the cell surface, then the surface pool of gpl40 would rep- 
resent 0.002 % total cell protein.  This suggests the existence 
of a large intracellular pool of gpl40 that is reactive with PB1 
in cell lysates but not in intact cells. The purified gpl40 was 
used to immunize a goat, and antibodies were obtained as de- 
scribed  in  Materials  and  Methods. 
Characterization of  Polyclonal Anti-gpl40 
NP-40 lysates of radioiodinated CHO cells were subjected to 
immunoprecipitation using goat anti-gpl40 IgG, preimmune 
goat IgG, or PB1 all covalently bound to Affi-gel 10.  Fig.  4 
shows the results.  The typical pattern of 1251 surface-labeled 
cells  is  shown  in  Fig.  4,  lane  d.  The  predominant  band 
precipitated  by goat  anti-gpl40  has  an  apparent  molecular 
mass of 140,000  D  (Fig.  4,  lane a) and aligns with the im- 
munoprecipitate of PB1 (Fig. 4, lane c). Thus, it appears that 
the goat anti-gp140 immunoprecipitates the same or similar 
species of surface protein  as PB1.  Fig.  4,  lane b  is the im- 
Figure  4.  Immunoprecipita- 
tions of CHO cell surface pro- 
teins  by  PB1  or  goat  anti- 
gpl40.  NP-40  extracts of L25I 
surface-labeled  CHO  cells 
(-,2  x  107 cells/sample) were 
immunoprecipitated with goat 
anti-gpl40 or NGIgG bound to 
Affigel-10;  alternatively  PB1 
monoclonal antibody coupled 
to Afligel-10  was used. Approx- 
imately 3  x  106 cell equiva- 
lents  were  loaded  on  each 
lane.  Samples were analyzed 
by SDS  PAGE (7.5%)  and detected by autoradiography.  (a) goat 
anti-gpl40;  (b) NGIgG; (c) PB1  monoclonal; (d) whole cells. 
munoprecipitation pattern of preimmune goat IgG, a control 
for nonspecific binding.  There is some nonspecific binding 
of the 140,000-D component as well as a band migrating with 
the molecular mass of 40-50 kD. However, the predominant 
band  specifically  immunoprecipitated  by  both  goat  anti- 
gpl40  and  PB1  is a  140,000-D  component. 
Because the goat anti-gpl40 polyclonal antibody precipi- 
tates a  protein  similar to that precipitated by PB1,  our next 
question  was  whether  goat anti-gpl40  was  also  specific  in 
blocking CHO cell adhesion to Fn. The data Fig.  5 presents 
indicates  that  the  polyclonal  antibody  is  as  functionally 
specific as the PB1 monoclonal. Thus goat anti-gpl40 blocks 
the adhesion  of CHO cells to Fn-coated  substrata but does 
not perturb the adhesion of the cells to Fn-depleted  serum- 
coated  substrata.  Such  substrata  should  contain  serum 
spreading  factors  but  not  Fn  (4).  Approximately  1  mg/ml 
goat anti-gpl40 was required to block 50% of CHO cell adhe- 
sion to Fn; this amount has no effect on adhesion of the cells 
to serum-coated  substrates.  Thus goat anti-gpl40,  like  PB1 
and PB2, specifically inhibits Fn-mediated adhesion, but not 
other adhesion  processes. 
Expression and Function of  gpl40-Related 
Protein in Human Cells 
A number of human cell types were screened for surface ex- 
pression  of  molecules  immunologically  related  to  CHO 
gpl40  using  the goat anti-gp140  in immunoprecipitation  of 
detergent  extracts  of  ~25I surface-labeled  cells.  As  Fig.  6 
shows,  the  polyclonal  antibody  specifically  precipitated 
surface-labeled  components  comigrating  with  CHO  cell 
gpl40  from human  diploid  fibroblasts  (HDF),  human  am- 
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Figure 5. Effect of goat anti-gpI40 on adhesion of CHO cells to Fn- 
coated or to serum-coated substrata. Tissue culture plates (24-well; 
Costar, Data Processing Corp., Cambridge, MA) were coated ei- 
ther  with  bovine  Fn  (100 ~tg/ml)  or  Fn-depleted  bovine  serum 
(20 %) in Eagle's essential minimum alpha medium. The wells were 
then co-coated with 1% bovine albumin. Each well was filled with 
1 ml of adhesion medium containing various dilutions of goat anti- 
gpl40 or of NGIgG. 2  x  105 CHO cells were added and incubated 
for 1 h at 4°C.  The cells were then warmed to 37°C  and allowed 
1 h to adhere. The fraction of cells adhering was determined as de- 
scribed in Materials and Methods.  (e  e), goat anti-gpl40 on 
a Fn substratum;  (e--  e),  goat anti-gpl40 on a  Fn free serum 
substratum;  (A),  NGIgG on a Fn substratum. 
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>(  107 cells were surface-labeled  with  1 mCi ~25I via the Iodogen 
surface-labeling  procedure  and  solubilized  with  1%  NP-40. The 
protein concentration was adjusted to 360 ~tg/ml and immunopre- 
cipitated  with  goat  anti-gpl40  or  NGIgG covalently coupled  to 
Atligel 10. Samples were solubilized in 125 ~tl sample buffer. 50 gl 
were applied to each lane of a 7.5% SDS polyacrylamide gel. La- 
beled proteins were visualized by autoradiography. Lane a, CHO 
cells:  lanes b and c, EFC cells; lanes d and e, WISH cells;  lanes 
fand g, HDF cells; lanes h and i, DAUDI cells; lanesj and k, hu- 
man erythrocytes. Lanes a, b, d,f, h, and j, goat anti-gpl40. Lanes 
c, e, g, i,  and k, NGIgG. 
nion cells (WISH),  human glioblastoma cells (EFC),  and 
human  lymphoblastoid  cells  (DAUDI).  No  specific  im- 
munoprecipitate was observed with extracts of human red 
blood cells. In the case of EFCs and DAUDI cells, 125I  com- 
ponents of lower molecular weight were found  in  the  im- 
munoprecipitates of both the specific and preimmune IgG. 
This  suggests  that  these  components  are  precipitation  ar- 
tifacts. 
Monolayers of CHO, HDF, WISH, and EFC cells on Fn 
substrata were treated with polyclonal anti-CHO gpl40.  As 
Fig.  7  shows,  CHO  ceils  were  completely  rounded  and 
detached by 10 mg/ml antibody. The other cell types were not 
completely prevented from adhesion by anti-gpl40,  but all 
displayed distinct morphological alterations. Thus, in WISH 
monolayers the lateral cell-to-cell contact seemed perturbed 
and the cells formed "islands" or patches, rather than an even 
monolayer. For EFC cells, the extension of long neurite-like 
processes seemed to be perturbed and the cells had a gener- 
ally rounded appearance. For HDF cells, the usual parallel 
orientation of these fibroblasts seemed perturbed. In no case, 
however, was the adhesion or spreading of the various human 
cell lines on Fn completely blocked by anti-gpl40. On sub- 
strata coated with Fn-depleted serum, neither CHO cells nor 
the  various  human  cell  lines  were  affected  by  10  mg/ml 
anti-gpl40 antibody (data not shown). 
Peptide Mapping 
Avian proteins involved in cell-matrix adhesion seem to be 
composed of a complex of three polypeptides (7,  18). These 
seem to be more clearly manifest when the proteins are run 
on gels under nonreducing  conditions.  For this  reason we 
elected to examine the migration of our affinity-purified ham- 
ster gpl40 under nonreducing conditions on 6% SDS PAGE. 
As seen in Fig 8 A, the gpl40 component can be resolved into 
two bands. In contrast to the case of avian adhesion proteins, 
no third band was detected under a  variety of gel analysis 
conditions.  The  two  bands  resolved  on  nonreducing  gels 
seem to be closely related polypeptides.  Two-dimensional 
maps of iodopeptides from U and L bands were very similar 
Figure 7. Effects of anti-gpl40 on the morphology  of human and 
hamster cell lines. Tissue culture plates were treated with 100 ~tg/ml 
bovine Fn and then co-coated with 1% bovine albumin. Various cell 
lines in adhesion medium were allowed 3 h at 37°C to adhere. The 
cells were then treated with 10 mg/ml of goat anti-gpl40 or NGIgG 
in adhesion buffer for 18 h at 37°C. Cell morphology was examined 
and photographed  using a Nikon Diaphot  inverted phase  micro- 
scope. (A and B) CHO cells;  (C and D) WISH cells;  (E and F) 
EFC cells; (Gand H) HDF cells; (A, C, E, and G) goat anti-gpl40; 
(B, D, F, and H) NGIgG. Bar, 15 tim. 
(Fig. 8, b and c), although the L band map showed three spots 
(marked A, B, and C,) not found in the U map. Another four 
spots (crosshatched in Fig. 8 C) were more intense in the U 
band map than the L  band map. These results suggest that 
there is a high degree of homology between U and L bands 
of gpl40, although some minor differences are clearly pres- 
ent. At present it is not clear if the U and L bands represent 
distinct polypeptides or if the observed small differences in 
peptide maps are due to proteolysis or to different posttrans- 
lational modifications. Interestingly, lower band consistently 
incorporated more cpm/mg protein using chloramine T radio- 
iodination, which suggests a greater abundance of tyrosine, 
histidine, and phenylalanine residues in this component (28). 
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gpl40. (A) Purified gpl40 was 
iodinated  using  Iodogen  R 
(Pierce Chemical Co.) with a 
resultant  sp act of 32 ~tCi/llg. 
20 ng of gpl40 having 1.4  x 
106 cpm were etectrophoresed 
on  6%  SDS  polyacrylamide 
gels  with  0.2%  linear  poly- 
acrylamide under reducing or 
nonreducing  conditions.  Un- 
der  nonreducing  conditions, 
gpl40 separates  into two dis- 
tinct  bands  (U  and  L)  that 
could be subsequently  cut out 
of the  gel.  (B)  For  two-di- 
mensional  peptide maps areas 
containing nonradiolabeled  U 
or L bands were identified by 
Coomassie  Blue  staining  of 
the gel and were sliced  from 
the  gel  and  ~25I labeled  in 
situ  using  chloramine  T  re- 
agent as described (28). Iodo- 
peptides  were  generated  by 
digestion  with  trypsin  and 
chymotrypsin (50 ~tg/ml each) 
overnight at 37°C.  The iodo- 
peptides  were  analyzed  by 
high  voltage  electrophoresis 
and  thin  layer  chromatogra- 
phy  and  detected  by  auto- 
radiography  (10). (A)  Affin- 
ity-purified  125I gpl40  under 
reducing (R) and nonreducing 
(NR)  conditions.  (B)  Two- 
dimensional  maps of ~25I  pep- 
tides  from U and L bands of 
gpl40. The peptides that seem 
distinct between the two bands 
are indicated  by A, B, and C 
in  L.  Vertical  direction,  thin 
layer  chromatography.  Hori- 
zontal  direction,  high  voltage 
electrophoresis.  (C)  Line 
drawings  of  peptide  maps. 
Spots  that  seem  distinct  be- 
tween  the  two  bands  are 
marked by A, B, and C in L. 
Spots that have a different  in- 
tensity in U than in L are cross 
hatched. 
Relation of  Hamster gpl40 to Other Adhesion Proteins 
We  have  compared  the  immunological  cross  reactivity  of 
hamster gpl40 with the recently described human gpl40 Fn 
receptor (26) and with the avian adhesion protein complex 
known as CSAT (15) or JG22  (7).  As seen in Fig.  9  A,  an 
afffinity-purified rabbit antibody against human gpl40 reacts 
with hamster gpl40, as does affinity-purified goat anti-ham- 
ster gpl40. Both antibodies can detect 20 ng of hamster gpl40 
at an IgG level of 1 Ixg/ml.  This indicates strong cross reac- 
tivity for the hamster and human gpl40 components. In Fig. 
9 B, the cross reactivity of gpl40 and CSAT antigen are com- 
pared.  Interestingly, rabbit anti-CSAT antiserum (1:20 dilu- 
tion), which detects CSAT antigen at levels of 0.2-1.0 ng, can 
also readily detect hamster gpl40 at levels of 1-5 ng.  How- 
ever,  goat anti-hamster  gpl40 IgG (100  Ixg/ml),  which de- 
tects gpl40 at  1-5 ng, does not react with CSAT antigen at 
levels  of up  to  500  ng.  Thus  epitopes  cross  reactive  with 
those in CSAT as well as unique epitopes are found on gpl40. 
Discussion 
Recent evidence  from our laboratory  (6)  and  from others 
(26) strongly suggests that cell surface glycoproteins of'x,140 
kD are critically involved in the Fn-mediated adhesion pro- 
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parison of gpl40 to other ad- 
hesion-related proteins. Ham- 
ster gp140 antigen and chick 
CSAT antigen blotted on ni- 
trocellulose  sheets  were  re- 
acted with goat anti-hamster 
gp140 IgG, rabbit anti-human 
140 kD Fn receptor IgG (26), 
or rabbit anti-CSAT antisera 
(23),  along with  appropriate 
control antibodies. Antibody- 
antigen binding was detected 
using a peroxidase-linked sec- 
ond  antibody. Goat  IgG and 
rabbit IgG dotted  into nitro- 
cellulose  served as  quantita- 
tion controls for detection by 
anti-goat  peroxidase  conju- 
gate or anti-rabbit peroxidase 
conjugate  respectively.  (A) Re- 
activity of hamster gp140 anti- 
gen with anti-hamster  gpl40 
or anti-human gpl40 antibod- 
ies. Primary antibodies. Lane 
1, normal goat IgG 100 I.tg/ml; 
lane  2,  goat  anti-hamster 
gpl40  100  ~tg/ml; lane  3, 
affinity  purified goat anti ham- 
ster gp140 10 Ixg/ml; lane 4, 
affinity purified goat anti hamster gpl40 1 lag/ml; lane 5, affinity purified rabbit anti human gpl40 1 ~g/ml; lane 6, normal rabbit IgG 1 
lag/ml. (B) Reactivity  of hamster gp140 or CSAT antigen. Le~ lanes 1-4, gpl40; Right lanes 1-4, CSAT. Lane 1, normal goat IgG 100 I.tg/ml; 
lane 2, goat anti-hamster  gpl40 100 lag/ml; lane 3, normal rabbit serum  1:20 dilution; lane 4, rabbit anti-CSAT serum  1:20 dilution. 
cess in some mammalian cell types. We have used PB1, a 
monoclonal antibody that recognizes gpl40,  a  putative Fn 
receptor in CHO cells, to purify this molecule to apparent 
homogeneity by SDS PAGE and to generate a polyclonal an- 
tibody to it. The polyclonal goat anti-gpl40 precipitates the 
same protein as PB1  from lysates of surface-labeled CHO 
cells and does not precipitate other components. Moreover, 
like PB1, the goat anti-gpl40 selectively blocks Fn-mediated 
adhesion but not other adhesion processes in CHO cells. 
Thus the goat anti-gpl40 is effectively  monospecific in react- 
ing with gpl40 on the CHO cell surface. We have not at this 
point investigated the reactivity of anti-gpl40 with lysates of 
metabolically labeled cells. Presumably the polyclonal anti- 
body would recognize intracellular precursor forms of gpl40 
as well as the fully processed molecule expressed at the cell 
surface. 
We have used the goat anti-gpl40 to probe the surface ex- 
pression and function of gpl40-related molecules in human 
cell  types.  Thus  the  goat  anti-gpl40  immunoprecipitates 
surface-labeled components of ~140 kD from several adher- 
ent human cell lines including HDF, WISH, and EFC. Treat- 
ment of these cells with anti-gpl40 induces changes in cell 
spreading and morphology. This suggests that gpl40-related 
molecules are expressed and function in Fn-mediated adhe- 
sion in a number of  adherent cell types. By contrast, erythro- 
cytes, a totally nonadherent cell, seem completely devoid of 
gpl40-related cell surface proteins. One should note, how- 
ever, that DAUDI cells, a lymphoblastoid line which, in our 
hands,  proved to be poorly adherent to Fn substrata,  also 
clearly expresses cell surface gpl40. Thus one cannot make 
a  simple  correlation between expression of gpl40-related 
molecules and adhesion to Fn. As we have shown elsewhere, 
cells have several ways of modifying their adhesive behavior 
in addition to modulation of surface receptor expression, for 
example, by modification of cAMP-protein kinase systems 
(9). 
At this point it is not clear why anti-gpl40 only partially 
affects the adhesion and morphology of the human cell types 
while fully blocking CHO cell adhesion. One possibility is 
that most of the antibodies in the anti-hamster gpl40 IgG 
fraction do not react with the site of the human gpl40 type 
molecule which functions in adhesion. Another possibility 
is that the human cell lines, but not CHO cells, can condition 
substrata by secretion of other (nonfibronectin) adhesion fac- 
tors during the rather protracted course (18 h) of the experi- 
ment. Consistent with this is our observation that anti-gpl40 
seems to strongly retard early stages of adhesion, but eventu- 
ally this block is partially overcome (data not shown). In any 
case it seems clear that perturbation of gpl40-1ike molecules 
can result in alteration in cell morphology. 
An important issue is whether or not gp140 is actually a 
receptor for Fn. Certainly formal pharmacological criteria 
for receptor status  have not been  met  for this  molecule. 
These criteria would include demonstration of specific, com- 
petable ligand binding to gpl40, and correlation of receptor 
occupancy and  biological  function.  Nonetheless,  the  evi- 
dence implicating gpl40 as a Fn receptor is at least strongly 
suggestive.  Thus,  (a)  monoclonal  antibodies  to  hamster 
gpl40 specifically block Fn-mediated hamster cell adhesion 
but not adhesion mediated by other ligands (18); (b) human 
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to human gpl40 strongly cross react with hamster gpl40 (this 
paper); and (d) polyclonal antibodies raised against hamster 
gpl40 but cross reactive with human gpl40 perturb morphol- 
ogy in human cells adhering  to Fn (this paper). All of these 
observations would suggest that hamster gpl40 is critically 
and specifically  involved in Fn-mediated  adhesion,  is im- 
munologically  closely  related  to  the  human  140-kD  Fn- 
binding protein, and thus is a good candidate  as a Fn recep- 
tor. One should keep in mind, however, that the identification 
of one receptor does not rule out the possible existence of 
other cell surface binding sites for Fn; in fact some lines of 
evidence strongly support  additional  sites (8,  21, 28). 
Another issue is the possible relationship between recently 
isolated mammalian gpl40 adhesion molecules (6,  26)  and 
previously described adhesion molecules in mammalian and 
avian cells. It seems very likely that the hamster cell gpl40 
described here is a member of a complex of partially purified 
adhesion-related cell surface glycoproteins described previ- 
ously (11, 19, 24). However, there seem to be some sharp dis- 
tinctions  as well as some similarities between the  140-kD 
mammalian Fn receptor protein described here and previ- 
ously described adhesion-related proteins (CSAT and JG22) 
in avian cells (7, 23). First, the avian adhesion proteins seem 
to be comprised of three  quite  distinct polypeptides in the 
ll0-160-kD range,  with rather unique one- and two-dimen- 
sional peptide maps  (14,  18). In contrast,  the mammalian 
gpl40 adhesion protein seems to be comprised of two closely 
related  polypeptides,  based  on one-  and  two-dimensional 
peptide mapping.  Second,  antibodies to the avian  proteins 
disrupt the adhesion of avian cells to complex, serum-coated 
substrata  (23)  where a  number of adhesion promoting li- 
gands such as vitronectin and other "spreading  factors" are 
present in addition to Fn (4); this suggests that the avian pro- 
teins  have  receptor functions  for more than  one adhesion 
ligand.  By contrast,  both monoclonal and polyclonal anti- 
bodies to mammalian gpl40 disrupt only Fn-mediated adhe- 
sion processes  and  not  adhesion  mediated by  vitronectin, 
laminin,  or  serum  spreading  factors  (6,  also  this  paper). 
Third,  there  is  direct  evidence  that  mammalian  gpl40 
specifically binds to Fn but not to other adhesion ligands (26, 
27).  By  contrast,  the  avian  adhesion complex (CSAT  and 
JG22) binds not only to Fn (2) but also to laminin (15).  Fi- 
nally, although anti-CSAT antibody  cross reacts with gpl40 
the converse is not true (Fig. 9); therefore gpl40 must have 
epitopes not found on the CSAT complex. Thus, the mam- 
malian  and  avian  adhesion  glycoproteins  seem to be bio- 
chemically, immunologically, and functionally distinct, de- 
spite a similarity in apparent molecular weight and a degree 
of immunlogical cross reactivity. 
In summary, present findings suggest that a 140-kD surface 
glycoprotein found in both hamster and human cells is criti- 
cally and specifically involved in Fn-mediated cell adhesion. 
The availability  of monoclonal and polyclonal antibodies to 
the  140-kD  component opens the path to rapid,  large  scale 
purification and analysis of biochemical and functional char- 
acteristics of this important  molecule. 
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